-
March 9, 2016 Lupin Completes its Acquisition of GAVIS
-
February 5, 2016 Lupin Limited – Quarter III Results, FY2016
-
February 2, 2016 Lupin Launches Generic Glumetza® HCI ER Tablets in the US
-
January 8, 2016 Lupin Receives FDA Approval for Generic Generess® Tablets
-
January 6, 2016 Lupin Launches Generic Ortho Tri-Cyclen® Lo Tablets
-
December 28, 2015 Lupin Receives FDA Approval for Generic Generess® Tablets
-
December 23, 2015 Lupin Receives FDA Approval for Potassium Chloride Extended Release Capsules
-
November 24, 2015 Lupin Receives FDA Approvals for Generic Loestrin® Fe 1/20 and Loestrin®1.5/30 Tablets
-
November 5, 2015 Lupin Appoints Thierry Volle as President – Europe, Middle-East & Africa (EMEA)
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications